COSM
Price
$0.59
Change
-$0.03 (-4.84%)
Updated
Dec 20, 04:59 PM (EDT)
SUPN
Price
$35.43
Change
-$0.34 (-0.95%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
Ad is loading...

COSM vs SUPN

Header iconCOSM vs SUPN Comparison
Open Charts COSM vs SUPNBanner chart's image
Cosmos Health
Price$0.59
Change-$0.03 (-4.84%)
Volume$592
CapitalizationN/A
Supernus Pharmaceuticals
Price$35.43
Change-$0.34 (-0.95%)
Volume$7.41K
CapitalizationN/A
COSM vs SUPN Comparison Chart
Loading...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COSM vs. SUPN commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COSM is a Hold and SUPN is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (COSM: $0.58 vs. SUPN: $35.43)
Brand notoriety: COSM and SUPN are both not notable
COSM represents the Medical Distributors, while SUPN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: COSM: 62% vs. SUPN: 292%
Market capitalization -- COSM: $11.96M vs. SUPN: $1.84B
COSM [@Medical Distributors] is valued at $11.96M. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COSM’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • COSM’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, SUPN is a better buy in the long-term than COSM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COSM’s TA Score shows that 4 TA indicator(s) are bullish while SUPN’s TA Score has 4 bullish TA indicator(s).

  • COSM’s TA Score: 4 bullish, 6 bearish.
  • SUPN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than COSM.

Price Growth

COSM (@Medical Distributors) experienced а -19.27% price change this week, while SUPN (@Pharmaceuticals: Other) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

COSM is expected to report earnings on Apr 12, 2023.

SUPN is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($1.84B) has a higher market cap than COSM($12M). SUPN YTD gains are higher at: 22.426 vs. COSM (-58.660). SUPN has higher annual earnings (EBITDA): 90M vs. COSM (-12.98M). SUPN has more cash in the bank: 255M vs. COSM (2.38M). COSM has less debt than SUPN: COSM (10.8M) vs SUPN (41.5M). SUPN has higher revenues than COSM: SUPN (608M) vs COSM (49.6M).
COSMSUPNCOSM / SUPN
Capitalization12M1.84B1%
EBITDA-12.98M90M-14%
Gain YTD-58.66022.426-262%
P/E RatioN/A1677.00-
Revenue49.6M608M8%
Total Cash2.38M255M1%
Total Debt10.8M41.5M26%
FUNDAMENTALS RATINGS
COSM vs SUPN: Fundamental Ratings
COSM
SUPN
OUTLOOK RATING
1..100
7375
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10046
SMR RATING
1..100
9879
PRICE GROWTH RATING
1..100
9044
P/E GROWTH RATING
1..100
694
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SUPN's Valuation (77) in the Pharmaceuticals Other industry is in the same range as COSM (79) in the null industry. This means that SUPN’s stock grew similarly to COSM’s over the last 12 months.

SUPN's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for COSM (100) in the null industry. This means that SUPN’s stock grew somewhat faster than COSM’s over the last 12 months.

SUPN's SMR Rating (79) in the Pharmaceuticals Other industry is in the same range as COSM (98) in the null industry. This means that SUPN’s stock grew similarly to COSM’s over the last 12 months.

SUPN's Price Growth Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for COSM (90) in the null industry. This means that SUPN’s stock grew somewhat faster than COSM’s over the last 12 months.

COSM's P/E Growth Rating (6) in the null industry is significantly better than the same rating for SUPN (94) in the Pharmaceuticals Other industry. This means that COSM’s stock grew significantly faster than SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COSMSUPN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 26 days ago
88%
Bullish Trend 7 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 6 days ago
70%
View a ticker or compare two or three
Ad is loading...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCREX14.560.23
+1.61%
BlackRock Real Estate Securities Inv C
AULYX102.461.07
+1.06%
American Century Ultra® Y
USCGX12.600.09
+0.72%
Victory Capital Growth
MSFBX32.860.20
+0.61%
Morgan Stanley Inst Global Franchise A
IMAAX9.280.04
+0.43%
Delaware Ivy Multi-Asset Income A

COSM and

Correlation & Price change

A.I.dvisor tells us that COSM and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COSM and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COSM
1D Price
Change %
COSM100%
-5.82%
YI - COSM
21%
Poorly correlated
+16.96%
SUPN - COSM
20%
Poorly correlated
-0.95%
SNYR - COSM
18%
Poorly correlated
-12.11%
OGI - COSM
16%
Poorly correlated
+6.85%
INCR - COSM
14%
Poorly correlated
+11.19%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with DVAX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then DVAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-0.95%
DVAX - SUPN
34%
Loosely correlated
-0.31%
AMRX - SUPN
30%
Poorly correlated
+0.39%
PBH - SUPN
29%
Poorly correlated
+0.08%
AQST - SUPN
28%
Poorly correlated
+0.27%
SNDL - SUPN
27%
Poorly correlated
+4.05%
More